Shukra Pharmaceuticals, 524632, Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,315.39
127.48
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,307.45
N/A
20.20

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

39.99
44.47
53.82

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
65.98
46.35

PAT CAGR (%)

10 Years
5 Years
3 Years

64.22
241.36
191.31

P:E (Median)

8 Years
5 Years
3 Years

21.99
30.50
29.46

P:BV (Average)

8 Years
5 Years
3 Years

3.99
4.33
6.39

EV:EBITDA (Average)

8 Years
5 Years
3 Years

16.17
19.85
25.48

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 5.39 3.18 69.50% 13.27 10.88 21.97% 10.58 18.89 -43.99% 5.55 24.64 -77.48%
Expenses 4.07 2.37 71.73% 5.95 6.45 -7.75% 6.65 9.35 -28.88% 4.89 19.55 -74.99%
EBITDA 1.32 0.80 65.00% 7.32 4.43 65.24% 3.94 9.54 -58.70% 0.67 5.09 -86.84%
EBIDTM 24.45% 25.33% 55.16% 40.74% 37.22% 50.52% 12.01% 20.65%
Other Income 1.11 0.72 54.17% 1.47 1.38 6.52% 1.01 0.56 80.36% 1.02 0.24 325.00%
Interest 0.27 0.06 350.00% 0.27 0.07 285.71% 0.15 0.07 114.29% 0.11 0.07 57.14%
Depreciation 0.79 0.66 19.70% 0.94 0.52 80.77% 0.70 0.51 37.25% 0.70 0.56 25.00%
PBT 1.37 0.80 71.25% 7.57 5.22 45.02% 4.10 9.53 -56.98% 0.88 4.70 -81.28%
Tax 0.34 0.31 9.68% 2.18 1.24 75.81% 0.93 0.11 745.45% 0.34 -0.01 -
PAT 1.03 0.49 110.20% 5.39 3.99 35.09% 3.17 9.42 -66.35% 0.54 4.71 -88.54%
PATM 19.09% 15.29% 40.59% 36.62% 29.90% 49.87% 9.70% 19.12%
EPS 0.02 0.01 100.00% 0.12 0.09 33.33% 0.07 0.22 -68.18% 0.01 0.11 -90.91%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 34.79 74.57 58.83 20.49 11.20 11.85 5.66 5.34 5.14 4.83 2.58 Net Sales Growth -39.59% 26.76% 187.12% 82.95% -5.49% 109.36% 5.99% 3.89% 6.42% 87.21% Cost Of Goods Sold 8.86 44.48 45.32 10.35 2.77 3.00 0.99 0.96 1.04 1.75 0.89 Gross Profit 25.93 30.09 13.52 10.14 8.43 8.84 4.67 4.39 4.09 3.07 1.69 GP Margin 74.54% 40.35% 22.98% 49.49% 75.27% 74.60% 82.51% 82.21% 79.57% 63.56% 65.50% Total Expenditure 21.56 55.17 53.47 17.60 9.75 10.31 4.01 3.73 3.67 3.64 2.82 Power & Fuel Cost - 0.00 0.00 0.00 1.78 1.64 0.34 0.29 0.26 0.26 0.28 % Of Sales - 0% 0% 0% 15.89% 13.84% 6.01% 5.43% 5.06% 5.38% 10.85% Employee Cost - 5.02 4.41 4.57 3.75 4.34 1.91 1.23 1.05 1.13 1.19 % Of Sales - 6.73% 7.50% 22.30% 33.48% 36.62% 33.75% 23.03% 20.43% 23.40% 46.12% Manufacturing Exp. - 0.13 0.12 0.09 0.05 0.03 0.02 0.02 0.02 0.00 0.01 % Of Sales - 0.17% 0.20% 0.44% 0.45% 0.25% 0.35% 0.37% 0.39% 0% 0.39% General & Admin Exp. - 2.95 3.36 2.50 1.35 1.29 0.73 1.22 1.12 0.32 0.44 % Of Sales - 3.96% 5.71% 12.20% 12.05% 10.89% 12.90% 22.85% 21.79% 6.63% 17.05% Selling & Distn. Exp. - 2.12 0.01 0.01 0.04 0.00 0.02 0.02 0.18 0.18 0.01 % Of Sales - 2.84% 0.02% 0.05% 0.36% 0% 0.35% 0.37% 3.50% 3.73% 0.39% Miscellaneous Exp. - 0.47 0.26 0.07 0.01 0.01 0.00 0.00 0.00 0.01 0.01 % Of Sales - 0.63% 0.44% 0.34% 0.09% 0.08% 0% 0% 0% 0.21% 0% EBITDA 13.25 19.40 5.36 2.89 1.45 1.54 1.65 1.61 1.47 1.19 -0.24 EBITDA Margin 38.09% 26.02% 9.11% 14.10% 12.95% 13.00% 29.15% 30.15% 28.60% 24.64% -9.30% Other Income 4.61 2.82 1.20 0.08 0.36 0.01 0.04 0.11 0.07 0.19 1.12 Interest 0.80 0.28 0.28 0.29 0.03 0.00 0.00 0.04 0.01 0.00 0.00 Depreciation 3.13 2.05 1.84 1.66 1.47 1.48 0.96 0.74 0.47 0.45 0.60 PBT 13.92 19.88 4.44 1.02 0.29 0.07 0.72 0.95 1.06 0.92 0.27 Tax 3.79 1.35 0.04 0.27 -0.09 0.14 0.26 0.42 0.56 0.23 0.14 Tax Rate 27.23% 6.79% 0.90% 26.47% -100.00% 82.35% 36.11% 44.21% 52.83% 65.71% 51.85% PAT 10.13 18.54 4.41 0.75 0.19 0.04 0.46 0.53 0.50 0.12 0.13 PAT before Minority Interest 10.13 18.54 4.41 0.75 0.19 0.04 0.46 0.53 0.50 0.12 0.13 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 29.12% 24.86% 7.50% 3.66% 1.70% 0.34% 8.13% 9.93% 9.73% 2.48% 5.04% PAT Growth -45.57% 320.41% 488.00% 294.74% 375.00% -91.30% -13.21% 6.00% 316.67% -7.69% EPS 0.23 0.42 0.10 0.02 0.00 0.00 0.01 0.01 0.01 0.00 0.00

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 57.64 25.30 16.35 15.60 15.41 15.38 15.01 14.58 14.07 13.95 Share Capital 10.95 3.91 1.57 1.57 1.57 1.57 1.57 1.57 1.57 1.57 Total Reserves 46.69 21.38 14.78 14.03 13.85 13.81 13.44 13.01 12.51 12.39 Non-Current Liabilities 6.04 7.16 6.39 12.97 11.15 9.02 6.43 2.64 2.48 3.48 Secured Loans 1.25 0.90 0.85 0.66 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 1.41 2.87 2.28 9.11 8.05 6.06 3.58 0.04 0.04 1.20 Long Term Provisions 0.11 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 14.15 42.51 12.38 7.03 6.99 4.00 2.66 1.72 0.73 0.88 Trade Payables 7.22 33.62 8.59 5.33 6.46 3.15 1.93 1.14 0.52 0.71 Other Current Liabilities 6.03 8.78 3.47 0.93 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 0.90 0.10 0.32 0.77 0.52 0.85 0.73 0.58 0.21 0.17 Total Liabilities 77.83 74.97 35.12 35.60 33.55 28.40 24.10 18.94 17.28 18.31 Net Block 19.94 20.23 17.58 17.69 17.38 15.60 14.12 10.09 9.67 9.72 Gross Block 41.33 39.57 35.08 33.53 31.74 28.51 26.06 21.30 20.41 20.01 Accumulated Depreciation 21.38 19.33 17.50 15.83 14.36 12.90 11.94 11.20 10.74 10.29 Non Current Assets 21.60 21.89 19.24 19.55 19.09 17.32 15.83 11.86 11.40 11.44 Capital Work in Progress 1.66 1.66 1.66 1.66 1.66 1.66 1.66 1.72 1.68 1.68 Non Current Investment 0.00 0.00 0.00 0.19 0.05 0.05 0.05 0.04 0.04 0.03 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 56.23 53.07 15.87 16.06 14.45 11.07 8.27 7.08 5.88 6.87 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 2.31 3.16 3.95 1.68 1.39 0.27 0.14 0.32 0.44 1.35 Sundry Debtors 24.51 30.19 7.40 9.75 7.95 5.35 2.93 2.47 0.94 0.52 Cash & Bank 9.98 3.97 0.29 0.50 0.13 0.25 0.06 0.52 1.74 0.59 Other Current Assets 19.43 7.97 0.17 0.14 4.99 5.20 5.14 3.77 2.77 4.41 Short Term Loans & Adv. 13.24 7.78 4.06 3.98 3.77 3.59 3.51 3.35 2.32 4.40 Net Current Assets 42.08 10.57 3.50 9.03 7.47 7.08 5.61 5.36 5.15 6.00 Total Assets 77.83 74.96 35.11 35.61 33.54 28.39 24.10 18.94 17.28 18.31

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -5.20 3.17 7.99 0.54 1.24 0.26 0.84 -0.29 2.72 -2.03 PBT 19.88 4.44 1.02 0.10 0.17 0.72 0.95 1.06 0.35 2.59 Adjustment 1.55 1.60 1.91 1.44 1.58 0.96 0.77 0.47 0.45 0.05 Changes in Working Capital -26.01 -2.62 5.50 -1.00 -0.51 -1.28 -0.74 -1.43 2.00 -4.47 Cash after chg. in Working capital -4.57 3.42 8.43 0.54 1.24 0.41 0.98 0.10 2.79 -1.83 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.00 0.00 0.00 Tax Paid -0.62 -0.25 -0.44 0.00 0.00 -0.15 -0.18 -0.39 -0.08 0.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.18 Cash From Investing Activity -1.20 -4.43 -1.53 -1.89 -3.11 -2.45 -4.75 -0.93 -0.41 0.73 Net Fixed Assets -1.76 -4.49 -1.55 -1.79 -3.23 -2.45 -4.70 -0.93 -0.40 -0.76 Net Investments 0.00 0.00 0.19 -0.14 0.00 0.00 -0.01 0.00 -0.01 0.02 Others 0.56 0.06 -0.17 0.04 0.12 0.00 -0.04 0.00 0.00 1.47 Cash from Financing Activity 12.40 4.94 -6.68 1.74 1.75 2.38 3.45 0.00 -1.16 1.38 Net Cash Inflow / Outflow 6.01 3.68 -0.21 0.38 -0.12 0.18 -0.46 -1.22 1.15 0.08 Opening Cash & Equivalents 3.97 0.29 0.50 0.13 0.25 0.06 0.52 1.74 0.59 0.51 Closing Cash & Equivalent 9.98 3.97 0.29 0.50 0.13 0.25 0.06 0.52 1.74 0.59

Financial Ratios

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 1.32 16.16 21.74 99.63 98.43 98.20 95.86 93.10 89.89 89.13 ROA 24.26% 8.01% 2.12% 0.54% 0.11% 1.76% 2.44% 2.78% 0.67% 0.72% ROE 44.70% 21.16% 4.70% 1.21% 0.23% 3.04% 3.55% 3.51% 0.85% 0.94% ROCE 44.24% 18.85% 5.79% 0.54% 0.77% 3.62% 5.94% 7.41% 2.40% 1.83% Fixed Asset Turnover 1.84 1.58 0.60 0.34 0.46 0.24 0.24 0.25 0.24 0.13 Receivable days 133.87 116.60 152.77 288.50 176.69 228.42 170.95 120.92 54.99 74.15 Inventory Days 13.39 22.06 50.20 50.01 22.02 11.47 14.59 26.67 67.13 171.85 Payable days 167.55 170.00 245.53 761.94 159.63 199.65 154.07 83.12 46.94 80.54 Cash Conversion Cycle -20.30 -31.34 -42.56 -423.43 39.09 40.24 31.47 64.47 75.18 165.46 Total Debt/Equity 0.05 0.20 0.21 0.63 0.52 0.39 0.24 0.00 0.00 0.09 Interest Cover 70.77 16.82 4.55 3.94 84.02 1166.32 24.45 182.99 256.48 204.27

Top Investors:

yogesh biharilal parikh

renuka yogesh parikh

llp

Annual Reports:

News Update:

Shukra Pharmaceuticals partners with Wockhardt
11th Sep 2025, 15:20 PM

The arrangement will strengthen the company’s presence in institutional and government healthcare networks across India
Read More
Shukra Pharmaceuticals bags contract from HSCC (India)
29th Aug 2025, 09:30 AM

The company has received a LoA on dated August 28, 2025 for the supply of Medicines and Diagnostic Kits to Afghanistan
Read More
Shukra Pharma - Quarterly Results
13th Aug 2025, 15:49 PM

Read More
Shukra Pharmaceuticals executes service agreement with APITCO
28th Jul 2025, 12:12 PM

This collaboration aims to contribute meaningfully to national-level developmental, industrial, and consulting initiatives
Read More
Shukra Pharmaceuticals inaugurates four new branch offices
10th Jul 2025, 12:00 PM

This expansion marks a pivotal step in its journey toward wider market engagement and operational reach
Read More

Shukra Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 524632 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Shukra Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 524632 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: